SHE:000999

3 stories mentioning SHE:000999Updated 28d ago

Every FINWIRES story that references SHE:000999, newest first.

China Resources Sanjiu's Attributable Profit Slides Nearly 8% in H1

China Resources Sanjiu Medical & Pharmaceutical's (SHE:000999) attributable profit fell 7.9% to 1.67 billion yuan in the first half from 1.81 billion yuan in the year-ago period, according to a Wednesday filing with the Shenzhen bourse.Earnings per share at the pharmaceutical company decreased 8.3% to 1 yuan from 1.09 yuan in the previous year.Operating revenue grew 1.4% year over year to 15 billion yuan from 14.8 billion yuan.

SHE:000999

Asia29d ago

CR Sanjiu's Profit Slips 7.9% in H1

China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) recorded a 7.9% decline in attributable profit for the first half of 2026 to 1.67 billion yuan from 1.82 billion yuan a year prior.Basic EPS fell to 1 yuan from 1.09 yuan in the corresponding period of the previous fiscal year, according to a Tuesday filing by parent China Resources Pharmaceutical (HKG:3320).The pharmaceutical company's operating revenue increased 1.4% to 15 billion yuan from 14.8 billion yuan previously.

HKG:3320SHE:000999

Asia108d ago

CR Sanjiu Medical & Pharmaceutical's Q1 Profit Drops 15%, Revenue Rises 19%; Shares Down 4%

China Resources Sanjiu Medical & Pharmaceutical's (SHE:000999) net profit attributable to shareholders in the first quarter fell 15% to 1.08 billion yuan from 1.27 billion yuan a year earlier, according to Shenzhen bourse filing on Saturday.The pharmaceutical company's shares dropped 4% during Monday's midday trade.Earnings per share dropped to 0.65 yuan from 0.76 yuan.Operating revenue rose 19% to 8.13 billion yuan from 6.85 billion yuan in the previous year.

SHE:000999

Track with the FINWIRES app suite

FolioX

Track SHE:000999 in your portfolio

WheelAI

Analyze SHE:000999 options with the wheel strategy

StockInsider

See market sentiment on SHE:000999